Is OmniAb (OABI)’s Eli Lilly (LLY) Partnership a Game Changer for OABI?
Covered in this story
What has happened since
- Omniab Inc is up 6.9% since this was published, 55 days ago.
- Lilly (Eli) is up 11.2% since this was published, 55 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Omniab Inc
- StoneX: $4.56 → $6 by Oct 2027 · Buy via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $OABI yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Omniab Inc →Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.